Eli Lilly and Company
Form 483 issued September 15, 2023 · Indianapolis, Indiana
- Inspection
- Sep 11 – Sep 15, 2023
- Observations
- 5
- Pages
- 5
- FEI number
- 1819470
In short: On September 15, 2023, FDA issued a Form 483 with 5 observations to Eli Lilly and Company in Indianapolis, Indiana (FEI 1819470) after an inspection that ran Sep 11 – Sep 15, 2023.
What FDA observed
Preview: the opening words of each observation- 01FDCA 505-1(f)(3)(A)
An application holder did not ensure healthcare providers (HCPs) who prescribe the drug are specially certified…
- 02FDCA 505-1(f)(3)(B)
An application holder did not ensure pharmacies that dispense the drug are specially certified, as required…
- 03FDCA 505-1(f)(3)(C)
An application holder did not ensure health care settings that dispense the drug are certified, as…
- 04FDCA 505-1(f)(3)(D)
An application holder did not ensure each patient receiving the drug has evidence or other documentation…
This inspection in context
Questions about this 483
What did FDA find at Eli Lilly and Company?
FDA listed 5 observations on this Form 483. The opening words of each observation are shown on this page.
When was Eli Lilly and Company inspected by FDA?
The inspection ran Sep 11 – Sep 15, 2023, and the Form 483 is dated September 15, 2023.
How do I get the full Form 483 for Eli Lilly and Company?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.